Sign up to save your podcasts
Or
Share ASCO25 Plenary!
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASCO25 Plenary!
הנה ASCO25 Plenary
עם שתי עבודות בגידולי GI
ATOMIC LBA1
https://ascopost.com/news/june-2025/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer
MATTERHORN LBA5
https://www.nejm.org/doi/full/10.1056/NEJMoa2503701
עם שתי עבודות בגידולי GI
ATOMIC LBA1
https://ascopost.com/news/june-2025/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer
MATTERHORN LBA5
https://www.nejm.org/doi/full/10.1056/NEJMoa2503701
View all episodes
By Dr. Einat Shacham Shmueli (MD)הנה ASCO25 Plenary
עם שתי עבודות בגידולי GI
ATOMIC LBA1
https://ascopost.com/news/june-2025/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer
MATTERHORN LBA5
https://www.nejm.org/doi/full/10.1056/NEJMoa2503701
עם שתי עבודות בגידולי GI
ATOMIC LBA1
https://ascopost.com/news/june-2025/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer
MATTERHORN LBA5
https://www.nejm.org/doi/full/10.1056/NEJMoa2503701